DAPA MET 5MG 1000MG XR TAB 14s

DAPA MET 5mg/1000mg XR Tablet 14s – SEO Description

DAPA MET XR 5mg/1000mg Tablet is an extended-release oral antidiabetic medication combining Dapagliflozin (5mg) and Metformin Hydrochloride (1000mg). This dual-action formula is used for the effective management of Type 2 Diabetes Mellitus, helping improve glycemic control by reducing glucose production and enhancing urinary glucose excretion. The extended-release formulation offers sustained blood sugar control with convenient once-daily dosing.

Key Features:

• Combination of SGLT2 inhibitor (Dapagliflozin) and biguanide (Metformin)

• Helps reduce HbA1c levels and fasting blood glucose

• Promotes weight loss and supports cardiovascular health

• Extended-release formula for prolonged effect and improved compliance

• Ideal for adults with Type 2 diabetes not controlled by monotherapy

Indications:

• Type 2 Diabetes Mellitus as an adjunct to diet and exercise

Pack Size: 14 tablets

Dosage: As prescribed by the physician

Manufacturer: [Insert Manufacturer Name Here]

Note: Not for use in Type 1 diabetes or diabetic ketoacidosis. Use under medical supervision.

Perfect for online pharmacies, diabetes care catalogs, and healthcare e-commerce listings.